Se connecter

Bibliographies thématiques / Ferric pyrophosphate

Sommaire

Articles de revues
Livres
Chapitres de livres
Actes de conférences

Littérature scientifique sur le sujet « Ferric pyrophosphate »

Auteur : Grafiati

Publié le 7 juin 2025

Mis à jour le 2 août 2025

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Ferric pyrophosphate ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Articles de revues sur le sujet "Ferric pyrophosphate"

1

Mallaci Bocchio, R., M. Lo Monaco, G. Natoli, S. Scibetta, and S. Corrao. "A Randomized Controlled Pilot Study to Compare the Efficacy of Different Iron Formulations: Sucrosomal Ferric Pyrophosphate, Micronized Microencapsulated Ferric Pyrophosphate, and Intravenous Ferric Gluconate." Current Topics in Nutraceutical Research 20, no. 4 (2022): 685–90. http://dx.doi.org/10.37290/ctnr2641-452x.20:685-690.

Texte intégral

Résumé :

Despite their gastrointestinal side effects, oral iron supplements are the first-line therapy in iron deficiency anemia. This study aims to compare different iron formulations in anemic outpatients. One-hundred and six outpatients with sideropenic microcytic hypochromic anemia (Hb < 12 g/dL for women, Hb < 13 g/dL for men) were enrolled and divided into two groups (Hb > 10 g/dL and Hb < 10 g/dL). One group was randomized (1:1) to receive sucrosomal ferric pyrophosphate or micronized microencapsulated ferric pyrophosphate, while the other group was randomized (1:1:1) to receive sucr

Styles APA, Harvard, Vancouver, ISO, etc.

2

Fidler, Meredith C., Thomas Walczyk, Lena Davidsson, et al. "A micronised, dispersible ferric pyrophosphate with high relative bioavailability in man." British Journal of Nutrition 91, no. 1 (2004): 107–12. http://dx.doi.org/10.1079/bjn20041018.

Texte intégral

Résumé :

Ferric pyrophosphate is a water-insoluble Fe compound used to fortify infant cereals and chocolate-drink powders as it causes no organoleptic changes to the food vehicle. However, it is only of low absorption in man. Recently, an innovative ferric pyrophosphate has been developed (Sunactive Fe™) based on small-particle-size ferric pyrophosphate (average size 0·3 μm) mixed with emulsifiers, so that it remains in suspension in liquid products. The aim of the present studies was to compare Fe absorption of micronised, dispersible ferric pyrophosphate (Sunactive Fe™) with that of ferrous sulfate i

Styles APA, Harvard, Vancouver, ISO, etc.

3

Fidler, Davidsson, Zeder, Walczyk, Marti, and Hurrell. "Effect of Ascorbic Acid and Particle Size on Iron Absorption from Ferric Pyrophosphate in Adult Women." International Journal for Vitamin and Nutrition Research 74, no. 4 (2004): 294–300. http://dx.doi.org/10.1024/0300-9831.74.4.294.

Texte intégral

Résumé :

The effects of added ascorbic acid and particle size on iron absorption from ferric pyrophosphate were evaluated in adult women (9–10 women/study) based on erythrocyte incorporation of iron stable isotopes (57Fe or 58Fe) 14 days after administration. Three separate studies were made with test meals of iron-fortified infant cereal (5 mg iron/meal) and the results are presented as geometric means and relative bioavailability values (RBV, FeSO4 = 100%). The results of study 1 showed that iron absorption was significantly lower from ferric pyrophosphate (mean particle size 8.5 mum) than from FeSO4

Styles APA, Harvard, Vancouver, ISO, etc.

4

Tarczykowska, Agata, Niklas Engström, Darja Dobermann, Jonathan Powell, and Nathalie Scheers. "Differential Effects of Iron Chelates vs. Iron Salts on Induction of Pro-Oncogenic Amphiregulin and Pro-Inflammatory COX-2 in Human Intestinal Adenocarcinoma Cell Lines." International Journal of Molecular Sciences 24, no. 6 (2023): 5507. http://dx.doi.org/10.3390/ijms24065507.

Texte intégral

Résumé :

We previously showed that two iron compounds that are orally ingested by humans, namely ferric EDTA and ferric citrate, can induce an oncogenic growth factor (amphiregulin) in human intestinal epithelial adenocarcinoma cell lines. Here, we further screened these iron compounds, plus four other iron chelates and six iron salts (i.e., 12 oral iron compounds in total), for their effects on biomarkers of cancer and inflammation. Ferric pyrophosphate and ferric EDTA were the main inducers of amphiregulin and its receptor monomer, IGFr1. Moreover, at the maximum iron concentrations investigated (500

Styles APA, Harvard, Vancouver, ISO, etc.

5

Sakaguchi, Rao, Nakata, Nanbu, and Juneja. "Iron Absorption and Bioavailability in Rats of Micronized Dispersible Ferric Pyrophosphate." International Journal for Vitamin and Nutrition Research 74, no. 1 (2004): 3–9. http://dx.doi.org/10.1024/0300-9831.74.1.3.

Texte intégral

Résumé :

Unlike commercial ferric pyrophosphate, micronized dispersible ferric pyrophosphate (MDFP: SunActive FeTM) does not precipitate and is completely dispersible in liquid form. MDFP shows a sharp particle size distribution at a nanometer level, which is several times smaller than that of commercial ferric pyrophosphate. The bioavailability of MDFP was compared to ferric pyrophosphate, sodium ferrous citrate, and ferrous sulfate by three bioavailability tests in rats; namely the serum iron concentration curve, the hemoglobin regeneration efficiency, and Association of Official Analytical Chemists'

Styles APA, Harvard, Vancouver, ISO, etc.

6

Divya, Sri Keerthika B. Priyanka B. P. Harith Mahesh Gomasa Dr. Swathi Boddupally*. "Study On Efficacy and Compliance of Oral Supplements with Ferric Pyrophosphate and Ferrous Ascorbate in Iron Deficiency Anaemia During Pregnancy." International Journal of Pharmaceutical Sciences 3, no. 5 (2025): 1080–86. https://doi.org/10.5281/zenodo.15354355.

Texte intégral

Résumé :

Background: Iron deficiency anaemia in pregnancy is a nutritional disorder characterized by insufficient iron levels, leading to reduced haemoglobin production. This condition poses significant risks to both maternal and fatal health including increased chances of preterm birth, low birth, weight and maternal morbidity. It often results from inadequate dietary intake, poor iron absorption, or increased iron requirements during pregnancy. Early diagnosis and appropriate management through iron supplementation and dietary adjustments are crucial to mitigate adverse outcomes and promote healthy p

Styles APA, Harvard, Vancouver, ISO, etc.

7

Tsuchita, Hiroshi, Atsuko Kobayashi, Tadashi Kojima, et al. "Bioavailability of iron from ferric pyrophosphate." Journal of Agricultural and Food Chemistry 39, no. 2 (1991): 316–21. http://dx.doi.org/10.1021/jf00002a020.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

8

Pratt, Raymond, Garry J. Handelman, Thomas E. Edwards, and Ajay Gupta. "Ferric pyrophosphate citrate: interactions with transferrin." BioMetals 31, no. 6 (2018): 1081–89. http://dx.doi.org/10.1007/s10534-018-0142-2.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

9

Gupta, Ajay, Raymond Pratt, and Bhoopesh Mishra. "Physicochemical characterization of ferric pyrophosphate citrate." BioMetals 31, no. 6 (2018): 1091–99. http://dx.doi.org/10.1007/s10534-018-0151-1.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

10

Cercamondi, Colin I., Guus S. M. J. E. Duchateau, Rajwinder K. Harika, et al. "Sodium pyrophosphate enhances iron bioavailability from bouillon cubes fortified with ferric pyrophosphate." British Journal of Nutrition 116, no. 3 (2016): 496–503. http://dx.doi.org/10.1017/s0007114516002191.

Texte intégral

Résumé :

AbstractFe fortification of centrally manufactured and frequently consumed condiments such as bouillon cubes could help prevent Fe deficiency in developing countries. However, Fe compounds that do not cause sensory changes in the fortified product, such as ferric pyrophosphate (FePP), exhibit low absorption in humans. Tetra sodium pyrophosphate (NaPP) can form soluble complexes with Fe, which could increase Fe bioavailability. Therefore, the aim of this study was to investigate Fe bioavailability from bouillon cubes fortified with either FePP only, FePP+NaPP, ferrous sulphate (FeSO4) only, or

Styles APA, Harvard, Vancouver, ISO, etc.

Plus de sources

Livres sur le sujet "Ferric pyrophosphate"

1

Blokdijk, G. J. Ferric Pyrophosphate Citrate; Second Edition. CreateSpace Independent Publishing Platform, 2018.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Chapitres de livres sur le sujet "Ferric pyrophosphate"

1

Salgueiro, María Jimena, and José Boccio. "Ferric Pyrophosphate as an Alternative Iron Source for Food Fortification." In Handbook of Food Fortification and Health. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-7076-2_7.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Actes de conférences sur le sujet "Ferric pyrophosphate"

1

Ge, Liuqin, Meisheng Xia, Zhitong Yao, and Qingping Sun. "Ferric pyrophosphate: A versatile and alternative iron fortification compound." In 2015 International Conference on Food Hygiene, Agriculture and Animal Science. WORLD SCIENTIFIC, 2016. http://dx.doi.org/10.1142/9789813100374_0013.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!